Marcus Y. Chin
Denali Therapeutics (United States)
ORCID: 0000-0002-7037-1603Also affiliated with Sunesis (United States)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 9 papers. Top paper: “Functional genomics of OCTN2 variants informs protein-specific variant effect predictor for Carnitine Transporter Deficiency”.
Gregory McInnes, Julia E. H. Brown, Neil Thomas, Keino Hutchinson, Marcus Y. Chin +8 more
Tanya Weerakkody, Hanna Sabelström, David Tatarakis, Jung H. Suh, Marcus Y. Chin +26 more
Brenda L. Rooney, Frank McCarthy, Wenlong Xia, Indigo V.L. Rose, Sophie Bax +9 more
Kean-Hooi Ang, Julia L. Davies, Carolina Alquézar, Virginia Garda, Brenda L. Rooney +5 more
Brenda L. Rooney, Frank McCarthy, Wenlong Xia, Indigo V.L. Rose, Sophie Bax +9 more
Seungyoon B. Yu, Isaac Cohen, Melania H. Fanok, Wei Luan, Romeo Maciuca +38 more
Anand Patwardhan, Kean-Hooi Ang, Austin L. Wang, Carolina Alquézar, Mackenzie Welch +6 more
Hanna Sabelström, Shan V. Andrews, Jean Paul Chadarevian, Marcus Y. Chin, David Tatarakis +46 more
Jether Amos Espinosa, Grace Pohan, Sarine Markossian, Michelle R. Arkin, Marcus Y. Chin